194 related articles for article (PubMed ID: 15557364)
1. Control of plasma nitric oxide bioactivity by perfluorocarbons: physiological mechanisms and clinical implications.
Rafikova O; Sokolova E; Rafikov R; Nudler E
Circulation; 2004 Dec; 110(23):3573-80. PubMed ID: 15557364
[TBL] [Abstract][Full Text] [Related]
2. Direct detection of S-nitrosothiols using planar amperometric nitric oxide sensor modified with polymeric films containing catalytic copper species.
Cha W; Lee Y; Oh BK; Meyerhoff ME
Anal Chem; 2005 Jun; 77(11):3516-24. PubMed ID: 15924383
[TBL] [Abstract][Full Text] [Related]
3. Perfluorochemical erythrocyte substitutes: disposition and effects on drug distribution and elimination.
Ravis WR; Hoke JF; Parsons DL
Drug Metab Rev; 1991; 23(3-4):375-411. PubMed ID: 1935577
[TBL] [Abstract][Full Text] [Related]
4. Physiological effects of a perfluorochemical blood substitute in beagle dogs.
Hoke JF; Ravis WR; Hankes GH; Spano J
Res Commun Chem Pathol Pharmacol; 1991 Sep; 73(3):315-32. PubMed ID: 1719593
[TBL] [Abstract][Full Text] [Related]
5. Effects of perfluorocarbon infusion in an anesthetized swine decompression model.
Spiess BD; Zhu J; Pierce B; Weis R; Berger BE; Reses J; Smith CR; Ewbank B; Ward KR
J Surg Res; 2009 May; 153(1):83-94. PubMed ID: 18541265
[TBL] [Abstract][Full Text] [Related]
6. Formation and role of plasma S-nitrosothiols in liver ischemia-reperfusion injury.
Glantzounis GK; Rocks SA; Sheth H; Knight I; Salacinski HJ; Davidson BR; Winyard PG; Seifalian AM
Free Radic Biol Med; 2007 Mar; 42(6):882-92. PubMed ID: 17320770
[TBL] [Abstract][Full Text] [Related]
7. Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin.
Seabra AB; Fitzpatrick A; Paul J; De Oliveira MG; Weller R
Br J Dermatol; 2004 Nov; 151(5):977-83. PubMed ID: 15541075
[TBL] [Abstract][Full Text] [Related]
8. Transport of nitric oxide by perfluorocarbon emulsion.
Ortiz D; Cabrales P; Briceño JC
Biotechnol Prog; 2013; 29(6):1565-72. PubMed ID: 23966236
[TBL] [Abstract][Full Text] [Related]
9. [Function of the mononuclear phagocyte system after administration of emulsions of perfluorinated carbon compounds].
Vishnevetskiĭ FE; Golubev AM; Beloiartsev FF; Vasil'ev AE; Pokrovskiĭ IuE
Biull Eksp Biol Med; 1987 Feb; 103(2):232-6. PubMed ID: 3814812
[TBL] [Abstract][Full Text] [Related]
10. The vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, is impaired in conscious spontaneously hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):476-90. PubMed ID: 16697269
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic studies of S-nitrosothiol formation by NO*/O2 and by NO*/methemoglobin.
Herold S; Röck G
Arch Biochem Biophys; 2005 Apr; 436(2):386-96. PubMed ID: 15797251
[TBL] [Abstract][Full Text] [Related]
12. Effects of a new perfluorocarbon emulsion on human plasma and whole-blood viscosity in the presence of albumin, hydroxyethyl starch, or modified fluid gelatin: an in vitro rheologic approach.
Jouan-Hureaux V; Audonnet-Blaise S; Lacatusu D; Krafft MP; Dewachter P; Cauchois G; Stoltz JF; Longrois D; Menu P
Transfusion; 2006 Nov; 46(11):1892-8. PubMed ID: 17076843
[TBL] [Abstract][Full Text] [Related]
13. One-electron reduction of S-nitrosothiols in aqueous medium.
Manoj VM; Mohan H; Aravind UK; Aravindakumar CT
Free Radic Biol Med; 2006 Oct; 41(8):1240-6. PubMed ID: 17015170
[TBL] [Abstract][Full Text] [Related]
14. Application of a stable-isotope dilution technique to study the pharmacokinetics of human 15N-labelled S-nitrosoalbumin in the rat: possible mechanistic and biological implications.
Warnecke A; Luessen P; Sandmann J; Ikic M; Rossa S; Gutzki FM; Stichtenoth DO; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1375-87. PubMed ID: 19070554
[TBL] [Abstract][Full Text] [Related]
15. S-nitrosothiol detection via amperometric nitric oxide sensor with surface modified hydrogel layer containing immobilized organoselenium catalyst.
Cha W; Meyerhoff ME
Langmuir; 2006 Dec; 22(25):10830-6. PubMed ID: 17129067
[TBL] [Abstract][Full Text] [Related]
16. Perfluorocarbon-based oxygen delivery.
Riess JG
Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):567-80. PubMed ID: 17090429
[TBL] [Abstract][Full Text] [Related]
17. Specific transport of S-nitrosocysteine in human red blood cells: Implications for formation of S-nitrosothiols and transport of NO bioactivity within the vasculature.
Sandmann J; Schwedhelm KS; Tsikas D
FEBS Lett; 2005 Aug; 579(19):4119-24. PubMed ID: 16023102
[TBL] [Abstract][Full Text] [Related]
18. Effect of a perfluorochemical erythrocyte substitute on the in vitro metabolism of lidocaine using rat liver slices.
Hoke JF; Ravis WR
Res Commun Chem Pathol Pharmacol; 1991 Sep; 73(3):333-53. PubMed ID: 1947444
[TBL] [Abstract][Full Text] [Related]
19. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous catalytic generation of nitric oxide from S-nitrosothiols at the surface of polymer films doped with lipophilic copperII complex.
Oh BK; Meyerhoff ME
J Am Chem Soc; 2003 Aug; 125(32):9552-3. PubMed ID: 12903997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
